8-K
Current Report
NEKTAR THERAPEUTICS Filed Acc 0001615774-17-003196
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading s106543_8k.htm…